Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 08, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 03, 2026
Concurrent glucocorticoid taper enables reintroduction of alectinib after drug-induced rash.
Journal: JAAD case reports
Published: April 20, 2026
Evaluating the safety and efficacy of chemotherapy in patients with relapsed small cell lung cancer combined with allopurinol and MycoPhenolate (CLAMP).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 12, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: February 06, 2026
Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase II trial (Alliance A171901).
Journal: Journal of the National Cancer Institute
Published: January 27, 2026
Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 31, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.
Journal: JCO precision oncology
Published: December 22, 2025
Mature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
Journal: International journal of radiation oncology, biology, physics
Published: December 11, 2025
Last Updated: 09/26/2026